Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
June 1
 · 
Reactions
MyLeukemiaTeam

It sounds like the question is: "I'm taking Pegasys (interferon alfa-2a) 90 micrograms for leukemia with systemic mastocytosis — what other treatment options are available if this doesn't work?"

If Pegasys isn't providing the results needed, there are several other treatment paths that a doctor might consider for leukemia Show Full Answer

It sounds like the question is: "I'm taking Pegasys (interferon alfa-2a) 90 micrograms for leukemia with systemic mastocytosis — what other treatment options are available if this doesn't work?"

If Pegasys isn't providing the results needed, there are several other treatment paths that a doctor might consider for leukemia. Here's a general overview of options that are often explored:

Targeted Therapy
- Drugs that block specific proteins on cancer cells, leaving healthy cells largely unaffected
- These are often used when other treatments stop working

Chemotherapy
- Different chemotherapy regimens may be tried if the current treatment isn't effective
- Sometimes a combination of drugs works better than a single medication

Stem Cell Transplant
- This is considered one of the more aggressive options
- It involves replacing unhealthy bone marrow cells with healthy donor cells
- It carries serious risks, so it's usually considered based on age and overall health

Clinical Trials
- Newer experimental treatments are constantly being studied
- These may be worth asking a doctor about, especially if standard treatments aren't working It's really important to have an open conversation with a hematologist or oncologist about which of these options best fits the specific situation, especially given the systemic mastocytosis. They can weigh factors like age, overall health, and how the leukemia is responding to current treatment.

June 1

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
Australia

A MyLeukemiaTeam Member asked a question 💭
Australia

A MyLeukemiaTeam Member asked a question 💭
Australia

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In